The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis.

Ke XuTao LiuJie ZhangYangang ZhouFang YangTao Ren

Published in: International journal of clinical oncology (2020)

Metronomic oral vinorelbine monotherapy has a certain effect on patients with stage IIIB/IV and advanced NSCLC, especially for untreated elderly patients. It offers the advantages of convenience, lower cost and acceptable incidence of severe adverse events.

Keyphrases

combination therapy
open label
small cell lung cancer
phase ii study
risk factors
oxidative stress
early onset
clinical trial
squamous cell carcinoma
randomized controlled trial
advanced non small cell lung cancer
locally advanced